The neuromodulation developer Saluda Medical announced that it raised $100 million to help bolster the sales of its ...

Neurostimulation IndustryThe global neurostimulation industry is projected to experience substantial growth, with its ...

Neuroprosthetics research has entered a stage in which animal models and proof-of-concept studies are translated into ...

In September, the company secured approval from the Bellberry Human Research Ethics Committee to initiate the first-in-human clinical trial in Australia for its GLP-1 implant. "Vivani begins ...

Brain computer interface (BCI) company Neuralink has been given regulatory approval to start a new trial of its implant to see if it can be used to control a robotic arm. If it proves to be ...

A rheumatoid arthritis patient has become the first of five to be implanted ... the neurostimulator and the development of the controlling software. Now, the start of human trials now means ...

Energy equipment and services provider Flowco launched the year’s first major IPO, planning to raise $392 million and list in ...

Nalu Medical, Inc. ("Nalu"), a leader in peripheral nerve stimulation, announced the publication of a study in Pain Management journal showing that the use of Nalu PNS therapy in chronic pain patients ...